Online citations, reference lists, and bibliographies.
← Back to Search

Effect Of Lyophilization On Liposomal Encapsulation Of Salmon Calcitonin

Janani Swaminathan, C. Ehrhardt
Published 2014 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract Purpose: The intent of this work was to assess the impact of lyophilization on the encapsulation of salmon calcitonin (sCT) into liposomes. Methods: Four different liposomal formulations were investigated, i.e. DPPC:Chol:DSPE-PEG2000 (75:20:5 and 65:30:5) and DPPC:Chol (80:20 and 66.7:33.3). Lipid films were prepared and hydrated with loading buffer containing sCT and different concentrations of the cryoprotectant, trehalose dihydrate. The liposomes were lyophilized, reconstituted and extruded to obtain small unilamellar vesicles. Non-encapsulated sCT was separated by gel filtration. Non-lyophilized formulations and liposomes lyophilized without the cryoprotectant were used as controls. Liposomes were analyzed for particle size, polydispersity index, zeta-potential and encapsulation efficiency. 31P-NMR (phosphorous nuclear magnetic resonance spectroscopy) was performed on selected formulations. Results: Post-lyophilization, no significant change in particle sizes and zeta-potentials were noted, regardless of the presence or absence of the cryoprotectant. Encapsulation efficiencies, however, increased following lyophilization, in both PEGylated (lyophilization control batch) and non-PEGylated liposomes (cryoprotectant batches only). 31P-NMR revealed the presence of two distinct vesicle populations – liposomes and micelles – in PEGylated formulation. The presence of micelles might be responsible for the observed encapsulation enhancement of sCT in the PEGylated formulation. Conclusions: Lyophilization resulted in an increase in encapsulation efficiency of sCT in PEGylated liposomes, even in the absence of a cryoprotectant, due to presence of micellar vesicles.
This paper references
10.1016/j.tibtech.2009.07.009
Therapeutic application of peptides and proteins: parenteral forever?
Zuzana Antošová (2009)
10.1016/S0168-3659(03)00160-3
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Kenji Yamabe (2003)
10.1016/j.jcis.2008.05.051
Dynamic and structural aspects of PEGylated liposomes monitored by NMR.
C. Leal (2008)
Development of dry powder system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration
Y Ohmori (2006)
10.1080/02652040010000334
Characterization of calcitonin-containing liposome formulations for intranasal delivery.
S. Law (2001)
10.2217/17435889.1.3.297
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
M. Immordino (2006)
10.1016/j.ejps.2010.08.010
Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure.
B. Stark (2010)
10.1016/0003-2697(80)90269-9
Colorimetric determination of phospholipids with ammonium ferrothiocyanate.
J. C. Stewart (1980)
10.2174/138920109787048634
Advances in peptide pharmaceuticals.
C. Stevenson (2009)
10.1016/0005-2736(80)90391-0
Effects of tumbling and lateral diffusion on phosphatidylcholine model membrane 31P-NMR lineshapes.
E. Burnell (1980)
10.1080/10611860802201134
Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery.
R. C. Bi (2008)
10.1016/J.LFS.2005.12.049
Development of dry powder inhalation system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration.
Y. Ohmori (2006)
10.1016/J.JCONREL.2005.05.016
Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
Keon-Hyoung Song (2005)
10.1081/LPR-100108460
ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES
S. Law (2001)
10.1089/jamp.2013.1049
Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Janani Swaminathan (2014)
10.1016/j.jconrel.2009.10.024
An overview of liposome lyophilization and its future potential.
Chengjun Chen (2010)
10.1007/s00198-007-0490-1
Salmon calcitonin: a review of current and future therapeutic indications
C. Chesnut (2007)
10.1016/S0168-3659(02)00238-9
Preparation and evaluation of proliposomes containing salmon calcitonin.
Keon-Hyoung Song (2002)
10.1006/CRYO.1997.2050
Enhanced permeability of freeze-dried liposomal bilayers upon rehydration.
W. Zhang (1997)
10.1007/s11095-012-0688-6
In Vitro and In Vivo Characterisation of PEG-Lipid-Based Micellar Complexes of Salmon Calcitonin for Pulmonary Delivery
L. Baginski (2012)
10.1016/S0006-3495(97)78861-1
Phosphatydylglycerol promotes bilayer insertion of salmon calcitonin.
J. Bradshaw (1997)
10.1023/A:1012142520912
Effect of Freezing Rate on the Stability of Liposomes During Freeze-Drying and Rehydration
E. C. V. van Winden (2004)
10.1016/S0378-5173(97)00222-6
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN).
Schwarz (1997)
10.1002/DDR.10162
In vivo efficacy of a novel double liposome as an oral dosage form of salmon calcitonin
Yoshinori Ebato (2003)
10.1529/BIOPHYSJ.105.079475
Calcitonin forms oligomeric pore-like structures in lipid membranes.
M. Diociaiuti (2006)
10.1016/j.cryobiol.2008.10.125
The stabilisation of purified, reconstituted P-glycoprotein by freeze drying with disaccharides.
A. Heikal (2009)
10.1210/ENDO-115-2-757
Liposome entrapment enhances the hypocalcemic action of parenterally administered calcitonin.
Masao Fukunaga (1984)
10.1208/s12249-010-9391-2
Naked Plasmid DNA Formulation: Effect of Different Disaccharides on Stability after Lyophilisation
S. G. L. Quaak (2010)
10.1016/j.peptides.2009.03.018
Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery
Ming Chen (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar